search icon
  • Print
  • ShareThis
  • Text Size
  • HIVMA Testimony to the Senate for Fiscal Year 2012 Appropriations

    Testimony Submitted for the Record to the Subcommittee on Labor, Health and Human Services, Education and Related Agencies on FY 2012 Appropriations for HIV/AIDS Programs.

    The U.S. investment in HIV/AIDS programs has revolutionized HIV care globally,, making HIV treatment one of the most effective medical interventions available. A vibrant research agenda and rapid public health implementation of scientific findings have transformed the HIV epidemic, reducing morbidity and mortality due to HIV disease by nearly 80 percent in the U.S.


    Implementation of health care reform and the Administration’s plans for a National HIV/AIDS Strategy offer promise for making significant progress in reducing the impact of the domestic HIV epidemic. However, their success will depend on maintaining adequate investments in the health care safety net, and in prevention, public health and research programs. The funding requests in our testimony largely reflect the consensus of the Federal AIDS Policy Partnership (FAPP), a coalition of HIV organizations from across the country, and are estimated to be the amounts necessary to sustain and strengthen our investment in combating HIV disease.

    Read the full Testimony (PDF)  PDF

| IDSA | Contact Us

© Copyright HIVMA 2018 HIV Medicine Association

Full Site Mobile Site